• Learn how you can return your patients to prostate health:
    To learn more about Greenlight™ Laser Therapy, an advanced treatment for benign prostatic hyperplasia (BPH), or to help you discuss this new option with your BPH patients, click here to locate a GreenLight Workshop near you.
  • Safely and effectively treats enlarged prostate glands, even > 60 grams
    “The increased power and improved beam collimation of HPS (GreenLight™ High Performance System) results in greater vaporization efficiency, allowing physicians to work through larger glands more quickly than they could previously,” says Gregg Eure, M.D., Devine-Tidewater Urology, Div. of Urology of Virginia, Eastern Virginia Medical School, Norfolk, VA. “You don’t have the time limitations of TURP and concerns over TUR syndrome. This can eliminate the need to stage procedures, allowing physicians to treat large prostates in one session.”

    For more information about GreenLight Laser Therapy treatment advantages and GreenLight laser system design features, click here

GreenLight Laser Therapy

GreenLight™ Laser Therapy Superior Results Come from Superior Technology

GreenLight Laser Therapy offers clinical outcomes equivalent to Transurethral Resection of the Prostate (TURP) for the treatment of BPH, with fewer complications. Over 100 clinical articles and 150 published abstracts have proven the safety and efficacy of GreenLight: no significant risk of TUR syndrome, fluid absorption or blood transfusion, and less than 1% of reported cases of erectile dysfunction.

For more information, download the GreenLight Laser Therapy Clinical Study Summary (pdf).

GreenLight Laser Therapy. It’s Proven. It’s in the Data.

GreenLight Laser Therapy

Over 100 Published Clinical Articles

Over 135 Published Abstracts

Over 7 Years Clinical History

Over 300,000 Patients Treated World-Wide

Outcomes equivalent to TURP with fewer side effects and complications

  • Rapid & dramatic flow rate improvement
  • Widest patient selection: for mild to severe symptoms
  • Additional studies support the use of GreenLight in large glands, anti-coagulant, and high risk patients
  • Outpatient procedure
  • Less risk than TURP ; no significant risk of TUR syndrome
  • Less than 1% of patients reported erectile dysfunction
  • 14 hour mean catheterization time
  • Mild and short-lived irritative symptoms
  • Sustained efficacy out to five years
  • Quick return to normal activities